LIFECORE BIOMEDICAL, INC. Deferred Revenue
LIFECORE BIOMEDICAL, INC. (LFCR) had Deferred Revenue of $2.06 million as of 2018-08-26, per its 10-Q filed 2018-10-05.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-10-05
- 2018-08-26: Deferred Revenue, Current $2.06M.
- 2018-05-27: Deferred Revenue, Current $2.63M.
- 2018-02-25: Deferred Revenue, Current $1.91M.
- 2017-11-26: Deferred Revenue, Current $1.67M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-08-26 | $2.06M 10-Q · filed 2018-10-05 |
| 2018-05-27 | $2.63M 10-Q · filed 2018-10-05 |
| 2018-02-25 | $1.91M 10-Q · filed 2018-04-05 |
| 2017-11-26 | $1.67M 10-Q · filed 2018-01-05 |
| 2017-08-27 | $284.00K 10-Q · filed 2017-09-28 |
| 2017-05-28 | $310.00K 10-K · filed 2018-08-09 |
| 2017-02-26 | $429.00K 10-Q · filed 2017-04-07 |
| 2016-11-27 | $474.00K 10-Q · filed 2017-01-05 |
| 2016-08-28 | $706.00K 10-Q · filed 2016-09-29 |
| 2016-05-29 | $832.00K 10-K/A · filed 2018-03-15 |
| 2016-02-28 | $1.15M 10-Q · filed 2016-03-30 |
| 2015-11-29 | $381.00K 10-Q · filed 2016-01-07 |
| 2015-08-30 | $854.00K 10-Q · filed 2015-10-01 |
| 2015-05-31 | $843.00K 10-K · filed 2016-08-01 |
| 2015-03-01 | $1.10M 10-Q · filed 2015-04-02 |
| 2014-11-30 | $211.00K 10-Q · filed 2015-01-09 |
| 2014-08-31 | $1.06M 10-Q · filed 2014-10-08 |
| 2014-05-25 | $1.25M 10-K · filed 2015-07-31 |
| 2014-02-23 | $1.67M 10-Q · filed 2014-03-28 |
| 2013-11-24 | $1.28M 10-Q · filed 2014-01-03 |
| 2013-08-25 | $628.00K 10-Q · filed 2013-09-26 |
| 2013-05-26 | $1.25M 10-K · filed 2014-08-01 |
| 2013-02-24 | $931.00K 10-Q · filed 2013-04-04 |
| 2012-05-27 | $162.00K 10-K · filed 2013-08-07 |
| 2012-02-26 | $344.00K 10-Q · filed 2012-03-28 |
| 2011-11-27 | $355.00K 10-Q · filed 2012-01-05 |
| 2011-08-28 | $1.15M 10-Q · filed 2011-10-05 |
| 2011-05-29 | $2.66M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |